Navigation Links
Heart Failure Care Influenced by Insurance Coverage
Date:9/20/2011

By Steven Reinberg
HealthDay Reporter

MONDAY, Sept. 19 (HealthDay News) -- The quality of care people with heart failure receive, along with outcomes, are significantly influenced by what type of insurance patients have, a new study finds.

Medicare and Medicaid patients and those without health insurance are less likely to be given some essential treatments and tend to be hospitalized longer, researchers report. Medicaid patients were 22 percent more likely to die in the hospital than patients with private insurance, the researchers said.

"I wish the results revealed a different story," said lead researcher Dr. John R. Kapoor, an assistant professor of medicine at the University of Chicago Pritzker School of Medicine.

The findings reveal that disparities in heart failure care do exist and are associated with worse outcomes, he added, and these unequal practices should be corrected.

"It remains medicine's major unhealed wound that care continues to be tailored to individuals based on their pocketbook, and not their condition," he said. "Quality of care for all patients --- insured and uninsured -- is priceless."

The report will be published in the Sept. 27 issue of the Journal of the American College of Cardiology.

For the study, Kapoor's team collected data on 99,508 heart failure patients seen in 244 hospitals that are part of the American Heart Association's Get with the Guidelines Heart Failure quality program.

The researchers found that, even among these hospitals, insurance coverage had an influence on how the guidelines were applied.

For example, compared with privately insured patients, patients with Medicaid or no insurance were less likely to be given blood pressure drugs called beta blockers or have an implantable cardioverter-defibrillator prescribed or placed before leaving the hospital. A cardioverter-defibrillator automatically delivers a shock to the heart if the heart starts beating irregularly, to return the heartbeat to normal.

Other drugs that are part of the guidelines for treating heart failure were also less likely to be prescribed to those with Medicaid or no insurance, Kapoor's group found.

In addition, Medicaid and Medicare patients were also less likely to receive other blood pressure medication such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) and beta blockers, compared with privately insured patients, the researchers found.

Study co-author Dr. Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles, said there are many reasons for the disparities in quality of care based on who is paying the bill.

"Inequalities in access to specialist care during hospital admissions may explain some of the differences by insurance status," Fonarow said. "There may also be a bias among certain physicians and hospitals to not prescribe medications or therapies with life-prolonging benefits to patients based on whether the patient is well-insured or not. Patient insurance status is also correlated with socioeconomic status, which may in turn also influence care and outcomes."

"These shocking and equally disturbing findings call for physicians to pause and reflect on practice behaviors," Kapoor said. "Quality care should be a priority, irrespective of financial incentives."

Dr. Marvin Konstam, director of the CardioVascular Center at Tufts Medical Center in Boston and author of an accompanying journal editorial, said there are "blatant" examples throughout the health care system in which patients don't get proven therapies because they lack adequate insurance coverage.

He cited a decision in Arizona to halt paying for several types of organ transplants for Medicaid recipients.

"That's a decision that has since been rescinded, but that's an example of how in the current system there is a very great risk of making misguided arbitrary decisions and cutting off whole segments of the population from a proven therapy," he said.

That can range from decisions made by individual doctors for a particular patient all the way up to state and federal governments making decisions on whole classes of treatments, he said.

Konstam thinks decisions on care need to take into account the cost-effectiveness of therapies, not just the cost of the therapy itself. In addition, payment for care needs to be changed to make costs similar for patients across the board.

More information

For more on heart failure, visit the U.S. National Library of Medicine.

SOURCES: John R. Kapoor, M.D., Ph.D., assistant professor, medicine, University of Chicago Pritzker School of Medicine, Chicago; Gregg Fonarow, M.D., professor, cardiology, University of California, Los Angeles; Marvin Konstam, M.D., professor, cardiology, and director, CardioVascular Center, Tufts Medical Center, Boston; Sept. 27, 2011, Journal of the American College of Cardiology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Emergency treatment for heart attack improving but delays still occur
2. One-Third of Severe Heart Attack Patients Have Treatment Delays
3. Gene Variant May Raise Death Risk After Heart Bypass
4. Cholesterol Deposits Around Eyes Linked to Heart Risk
5. Drinking Patterns Affect Heart Health, Mouse Study Finds
6. Certain Risk Factors Could Spur Heart Failure in Normal-Weight People
7. U.S. Seeks to Prevent 1 Million Heart Attacks, Strokes
8. Heart Defect Seems to Pose Low Risk of Aorta Tear
9. Lifestyle Changes May Prevent Heart Failure
10. Newly Found Gene Mutations May Aid Heart Treatments
11. Muscle Training May Benefit Chronic Heart Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Heart Failure Care Influenced by Insurance Coverage
(Date:5/30/2016)... California (PRWEB) , ... May 30, 2016 , ... ... easy to use inside of FCPX," said Christina Austin - CEO of Pixel ... exclusively for use within Final Cut Pro X. Choose from abstract transitions to ...
(Date:5/29/2016)... ... May 29, 2016 , ... Whole Health Supply is happy to announce ... been available via Amazon.com. This new style of nail clipper has a wider jaw ... is approximately 4mm and the actual handle is 2.5mm thick to accommodate the cutting ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can ... drop a preset onto their media," said Christina Austin - CEO of Pixel Film ... can quickly and easily add stylish color grades to their footage. A LUT is ...
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses and professionals in ... lights on the variety of topics detailing why we appreciate nurses in so many ... career has gone from being in a major recession to one of the hottest ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... biopharmaceutical company focused on late-stage drug development, today ... Pharma of pivotal batches required for registration ... Administration (FDA). This follows Kitov,s announcement ... trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... May 26, 2016 TARE ... Both Cost Savings and Overall Decreased Use ... BTG), an international specialist healthcare company, has today ... 21st Annual Meeting of ISPOR (International Society for ... hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres is ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... dringenden Bedarf zur Steuerung ... N.V. (NASDAQ: QGEN ; Frankfurt Prime ... Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung und ... sein. Ein erstes Projekt wird die Entwicklung und ...
Breaking Medicine Technology: